U.S. Food and Staples Retail Stock News

NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept Therapeutics (CORT) Stock After 114% YTD Surge Is The Rally Justified

If you are wondering whether Corcept Therapeutics stock is still attractively priced after a strong run, the key question now is how its current share price compares with a reasonable view of fair value. The stock last closed at US$81.75, with returns of 4.6% over the past week, 48.3% over the past month, 114.0% year to date, 14.8% over the past year, 264.0% over three years, and 267.3% over five years. These figures naturally raise questions about how much of the story might already be...
NasdaqGS:WTW
NasdaqGS:WTWInsurance

Willis Towers Watson (WTW) Stock After 20% Slide This Year Is The Price Now Attractive

Wondering if Willis Towers Watson stock is priced attractively today or if the risks outweigh the potential reward? This article breaks down what the current share price might be implying. Willis Towers Watson last closed at US$260.03. While the stock has risen 1.2% over the past month, it is still down 20.3% year to date and 11.6% over the past year, with a gain of 16.1% over three years and 20.4% over five years. These mixed returns sit against an ongoing flow of industry and macro news...
NYSE:YUMC
NYSE:YUMCHospitality

Yum China (YUMC) Stock After Recent Weak Returns Is The Current Price Still Attractive

Wondering if Yum China Holdings stock still offers value at current levels, or if the recent moves have already priced in the story? This article walks through what the numbers are saying right now. The share price closed at US$43.28, with returns that declined 1.2% over the past week, 4.8% over the past month, and 10.2% year to date. Over longer periods, the share price has risen 3.5% over the past year and declined 20.9% over three years and 30.0% over five years. These shifts can change...
NasdaqGM:GHRS
NasdaqGM:GHRSPharmaceuticals

What GH Research (GHRS)'s Phase 2a Postpartum Depression Breakthrough Means For Shareholders

Earlier in June 2026, GH Research PLC reported full Phase 2a results for its inhaled Mebufotenin (GH001) in postpartum depression, showing rapid remission in all 10 patients, improved maternal functioning, and a favorable safety profile, with findings published in The Journal of Clinical Psychiatry and highlighted at the upcoming CINP 2026 congress. An additional practical insight from the trial was that drug levels in breast milk supported only a brief interruption of breastfeeding around...
NYSE:WLY
NYSE:WLYMedia

Wiley (WLY) Stock Faces 163% Earnings Rebound That Challenges Long‑Term Bearish Narratives

John Wiley & Sons (WLY) closed FY 2026 with fourth quarter revenue of US$447.9 million and basic EPS of US$2.65, supported by trailing twelve month EPS of US$4.22 on revenue of US$1.68 billion. Over recent periods, the company has seen quarterly revenue move from US$404.6 million in FY 2025 Q3 to US$442.6 million in FY 2025 Q4 and then to US$447.9 million in FY 2026 Q4. Basic EPS shifted from a loss of US$0.43 in FY 2025 Q3 to US$1.27 in FY 2025 Q4 and US$2.65 in FY 2026 Q4, alongside...
NasdaqGS:TRS
NasdaqGS:TRSPackaging

Do Upgraded Estimates And Momentum at TriMas (TRS) Reveal a Deeper Shift in Its Narrative?

In recent days, analysts highlighted that TriMas holds a Zacks Rank #2 (Buy) and a Momentum Style Score of B, supported by upward earnings estimate revisions and recent outperformance versus its industry and the broader market. This renewed analyst attention underscores how improving earnings expectations and momentum indicators can materially influence how investors assess TriMas' near-term prospects. We’ll now examine how the upgraded earnings estimates and momentum profile may influence...
NYSE:TX
NYSE:TXMetals and Mining

Should Upgraded Analyst Momentum and Valuation Views Require Action From Ternium (TX) Investors?

Recent research updates highlighted that Ternium S.A. received a favorable Zacks Rank #2 (Buy) and a Momentum Score of B, supported by upward earnings estimate revisions and stronger momentum signals relative to other steel producers. Analysts also pointed out that Ternium’s improving earnings outlook and valuation metrics have made it stand out versus peers like Commercial Metals, reinforcing its position as a preferred steel producer in current coverage. We’ll now examine how these upward...
NYSE:PHM
NYSE:PHMConsumer Durables

PulteGroup (PHM) Stock Could Be 35% Undervalued If This Housing Narrative Holds

PulteGroup (PHM) has drawn investor attention after recent share price moves, with the stock up 13.3% over the past month and 6.6% in the past 3 months, outpacing its shorter term returns. See our latest analysis for PulteGroup. Looking beyond the recent move, PulteGroup’s 1-year total shareholder return of 27.38% and 3-year total shareholder return of 70.49% indicate that the latest share price strength around $124.76 continues a broader period of positive momentum. If you want to see what...
NYSE:PB
NYSE:PBBanks

Prosperity Bancshares (PB) Stock Could Be 8.1% Undervalued on Its Texas Growth Narrative

Prosperity Bancshares (PB) stock has drawn attention after recent trading performance, with the shares closing at $71.60. Investors are assessing how the bank's current valuation compares with its profitability and growth profile. See our latest analysis for Prosperity Bancshares. The recent 1 month share price return of 7.67% and 3 month share price return of 11.72% suggest improving momentum for Prosperity Bancshares, while the 1 year total shareholder return of 10.19% points to steadier...
NasdaqGS:HST
NasdaqGS:HSTHotel and Resort REITs

Did HST’s Q1 Earnings Beat and Strong Travel Demand Just Shift Host Hotels & Resorts’ Investment Narrative?

Earlier in 2026, Host Hotels & Resorts reported first-quarter earnings and revenue that came in well above forecasts, powered by strong leisure travel and a recovery in group bookings across its luxury and upper-upscale portfolio. This performance underscored how Host’s focus on higher-end, experience-driven properties and reinvestment in its hotels is helping it capture robust room and non-room spending. Next, we’ll examine how this earnings beat, and the strength in both leisure and group...
NasdaqGM:CRMD
NasdaqGM:CRMDPharmaceuticals

Raised 2026 Guidance and DefenCath Momentum Might Change The Case For Investing In CorMedix (CRMD)

Earlier in 2026, CorMedix Inc. reported strong Q1 results driven by DefenCath and raised its full-year 2026 guidance while outlining progress on late-stage programs such as REZZAYO. Management also emphasized continued business momentum even as the company prepares for the expiration of temporary TDAPA reimbursement, highlighting execution in a changing reimbursement backdrop. Next, we will examine how CorMedix's raised 2026 guidance and DefenCath’s contribution shape the company’s broader...
NYSE:RIG
NYSE:RIGEnergy Services

Transocean (RIG) Stock After 74% Year Gain And Mixed Valuation Signals

While Transocean stock trades around US$5.59, you might be wondering whether that price reflects a bargain, a fair deal, or hidden risk in plain sight. Recent returns show a mixed picture, with the share price declining 4.8% over the past week and 20.6% over the past month, yet still up 31.8% year to date and 74.1% over the past year. These moves sit against a backdrop of ongoing interest in offshore drilling and changing sentiment around energy services stocks, which can quickly reshape how...
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

Ardelyx (ARDX) Stock Could Be 65% Undervalued As Growth Hopes Face Reassessment

Ardelyx (ARDX) is back in focus after recent trading, with the stock closing at $5.67 and showing mixed short term performance, including a decline over the past month and a gain over the past 3 months. See our latest analysis for Ardelyx. Looking beyond the latest move, Ardelyx’s share price return is down over the past month but slightly up over the past quarter, while its 1 year total shareholder return is strongly positive. This suggests earlier optimism is being reassessed rather than...
NYSE:ALSN
NYSE:ALSNMachinery

Allison Transmission (ALSN) Lands $250 Million CV90 Deal With BAE Systems

Allison Transmission Holdings (NYSE:ALSN) secured a record US$250 million contract to supply its advanced 4040 MX transmissions for BAE Systems’ CV90 MkIV tracked defense vehicles. The agreement is described as the largest tracked defense program deal in Allison Transmission’s history. The 4040 MX transmission will move from development into a full production platform under this contract, with deliveries scheduled to begin in 2028 after integration testing with BAE. For investors following...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

10x Genomics (TXG) Launches Cleveland Clinic Partnership For Bladder Cancer Diagnostics

10x Genomics (NasdaqGS:TXG) announced a multi-year research collaboration with Cleveland Clinic focused on bladder cancer diagnostics. The partnership centers on using single-cell, spatial transcriptomic, and protein profiling technologies to build multimodal cancer datasets. The collaborators plan to link molecular data with clinical outcomes, aiming to support future diagnostic applications across oncology. 10x Genomics enters this Cleveland Clinic collaboration with its stock at $31.75...
NYSE:CFG
NYSE:CFGBanks

Citizens Financial Group (CFG) Appoints Chris Emerson To Lead Investor Relations

Citizens Financial Group (NYSE:CFG) has appointed Chris Emerson as Head of Investor Relations, while he continues to lead Corporate Planning and Enterprise Finance. Kristin Silberberg is moving into the role of Chief Financial Officer of the Commercial Bank. These leadership changes place new executives in key financial and investor-facing positions at the company. Citizens Financial Group enters these leadership shifts with NYSE:CFG trading at $67.27. Over the past year, the stock is up...
NYSE:PK
NYSE:PKHotel and Resort REITs

Park Hotels & Resorts (PK) Stock After 58% One-Year Rally Are Valuation Gaps Closing?

If you are wondering whether Park Hotels & Resorts stock still offers value at around US$14.69, the key question is how its current price compares with what the business might reasonably be worth. The stock has returned 3.8% over the past week, 36.5% over the last month, 36.4% year to date, 58.3% over the last year, 64.2% over three years and 0.1% over five years, which can change how investors think about both upside potential and risk. Recent news coverage around Park Hotels & Resorts has...
NasdaqGS:VLY
NasdaqGS:VLYBanks

Valley National Bancorp (VLY) Stock After 75% One-Year Jump Are Valuation Gaps Closing

If you are looking at Valley National Bancorp stock and wondering whether the current price really reflects what you are getting, the valuation story is where things start to get interesting. The stock last closed at US$14.20, with returns of 0.6% over 7 days, 9.8% over 30 days, 21.5% year to date, 74.9% over 1 year, 100.1% over 3 years and 31.3% over 5 years, which gives plenty of context before comparing price to underlying value. Recent headlines have focused on Valley National Bancorp's...
NYSE:CRH
NYSE:CRHBasic Materials

Could Tony Will’s Board Role Reframe CRH’s (CRH) Capital Allocation and Portfolio Strategy?

CRH plc recently announced that former CF Industries CEO Tony Will, an experienced industrial and board leader with a background across manufacturing, consulting and transportation, will join its Board of Directors effective July 1, 2026. His blend of heavy-industry operating experience and current role on Union Pacific’s board adds expertise in large-scale capital allocation, logistics and governance that could influence CRH’s long-term decision-making. We’ll now examine how Tony Will’s...
NasdaqCM:ASLE
NasdaqCM:ASLEAerospace & Defense

3 Growth Companies With High Insider Ownership Expecting 61% Revenue Growth

Over the last 7 days, the United States market has risen by 2.3%, contributing to a robust 25% increase over the past year, with earnings forecasted to grow by 19% annually. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business in its potential for future success.
NasdaqCM:ALTI
NasdaqCM:ALTICapital Markets

AlTi Global And 2 Other Promising Penny Stocks To Watch

The United States market has experienced a robust climb, with a 2.3% increase in the last week and a significant 25% rise over the past year, while earnings are projected to grow by 19% annually. Amidst these favorable conditions, identifying stocks that combine affordability with growth potential is key, especially when considering penny stocks. Although the term 'penny stock' might seem outdated, these smaller or newer companies can still offer substantial opportunities for investors who...
NYSE:VZIO
NYSE:VZIOConsumer Durables

US Domestic Manufacturing Stocks One Tariff Winner One Margin Puzzle

US manufacturing stocks are back in focus as fresh tariff proposals, trade investigations, and the prospect of a new US-China Board of Trade reshape expectations for supply chains and costs. For investors, the question is which US Domestic Manufacturing Stocks could potentially benefit from this policy turn and which might face pressure as trade relationships evolve. This article highlights 3 stocks from the screener that are directly exposed to these trade headlines, explaining how the same...
NYSE:GWW
NYSE:GWWTrade Distributors

W.W. Grainger (GWW) Stock Could Be 4.3% Overvalued After Its Recent Run

W.W. Grainger (GWW) has drawn attention after recent trading, with the stock last closing at $1,319.72. Investors are weighing this move against its recent performance and the company’s current fundamentals. See our latest analysis for W.W. Grainger. Recent trading in W.W. Grainger sits against a backdrop of strong momentum, with a 30 day share price return of 3.71% and a 90 day share price return of 26.19%, while the 5 year total shareholder return of 213.89% points to a robust longer term...